Literature DB >> 22850759

The role of inter-segmental differences in P-glycoprotein expression and activity along the rat small intestine in causing the double-peak phenomenon of substrate plasma concentration.

Sho Wada1, Takashi Kano, Suzune Mita, Yoko Idota, Kaori Morimoto, Fumiyoshi Yamashita, Takuo Ogihara.   

Abstract

Conflicting results have been reported on segmental differences in expression of P-glycoprotein (P-gp) along the small intestine of animals and humans. In this study, we investigated P-gp mRNA and protein levels within each of nine segments of rat small intestine. In addition, P-gp activity in each segment was evaluated in terms of permeability of rhodamine123 (Rho123), a typical P-gp substrate, using the serial intestinal non-everted sac method. The P-gp mRNA levels tended to increase from the duodenum to the ileum, with peaks in the upper and lower ileum, while P-gp protein level reached its maximum in the middle ileum. The activity of P-gp was also the highest in the middle ileum, and was highly correlated with P-gp protein level. The double-peaked plasma concentration profile that was observed following oral administration of Rho123 to rats could be well reproduced by an intestinal compartmental kinetic model incorporating inter-segmental differences of absorption and excretion rate constants. Our results suggest that the heterogeneous distribution of P-gp along the small intestine plays a key role in causing the double-peak of plasma concentration of P-gp substrates following oral administration to rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850759     DOI: 10.2133/dmpk.dmpk-12-rg-005

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  2 in total

1.  Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.

Authors:  Mourad Hamimed; Pierre Leblond; Aurélie Dumont; Florence Gattacceca; Emmanuelle Tresch-Bruneel; Alicia Probst; Pascal Chastagner; Anne Pagnier; Emilie De Carli; Natacha Entz-Werlé; Jacques Grill; Isabelle Aerts; Didier Frappaz; Anne-Isabelle Bertozzi-Salamon; Caroline Solas; Nicolas André; Joseph Ciccolini
Journal:  Cancer Chemother Pharmacol       Date:  2022-06-25       Impact factor: 3.288

2.  Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.

Authors:  Jiapeng Li; Yang Liu; Jingru Zhang; Xiaotong Yu; Xiaoling Wang; Libo Zhao
Journal:  Drug Des Devel Ther       Date:  2016-11-15       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.